Business Wire: "Pro-Pharmaceuticals, Inc. (Amex:PRW), a developer of novel cancer therapeutics to target cancer cells through carbohydrate chemistry, today announced the U.S.
Patent & Trademark Office issued two U.S.
patents covering the Company's core carbohydrate drug targeting and delivery platforms. Pro-Pharmaceuticals is conducting Phase I human clinical trials of its DAVANAT(TM) combination with 5-FU. Cancer centers participating in the Phase I human trial are the
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center in Lebanon, NH; the University of Michigan Comprehensive Cancer Center in Ann Arbor, MI; the Ochsner Cancer Institute in New Orleans, LA, and Florida Oncology Associates in Jacksonville, FL.
More...
Two Nashua lawyers have unearthed copies of 14 early patents - including an 1826 patent for the first internal combustion engine - at a Dartmouth College library. Virtually all information about the first 10,000 U.S. patents was destroyed in a July 1839 fire that gutted the U.S. Patent and Trademark Office in Washington. The office was established in 1790. In the 168 years since the fire, only about 2,800 have been recovered. No one at the office can remember the last time some of the so-called “X-patents” were discovered, until this spring.
More...
Fifty years ago this spring Albert Einstein died in Princeton, N.J. One hundred years ago, as a young man, he published four papers in the leading German physics journal, Annalen der Physik, launching what would become known as his “miraculous year.” To commemorate both events, the General Assembly of the United Nations has declared 2005 to be the “World Year of Physics” (WYP2005).
